Categories
Alembic Pharmaceuticals Limited — Updates, 15-05-2026: Press Release
15-05-2026 · 02:54 pm
Alembic Pharma's latest quarterly Revenue increased 4% to ₹1,848 Cr, with Net Profit rising 29% to ₹203 Cr. A strategic highlight: the company launched its US branded business via Pivya, marking entry into the uUTI market for future growth.
No comments yet. Be the first to comment!